National / Science & Health Jan 13, 2020

Gene abnormalities occur in iPS cell conversion process

Cancer-related genetic abnormalities have reportedly occurred during the process of transforming induced pluripotent stem (iPS) cells supplied by Kyoto University into intended cell types at recipient research institutes. None of the affected iPS cells, which are used for regenerative medicine, have been used for transplantation, ...

Asahi Kasei to acquire U.S. drugmaker

Business / Corporate Nov 26, 2019

Asahi Kasei to acquire U.S. drugmaker

Major chemical maker Asahi Kasei Corp. has said it will purchase Veloxis Pharmaceuticals Inc. of the U.S. by February. The acquisition price will come to some ¥143.2 billion. Through the purchase of the U.S. drugmaker, Asahi Kasei hopes to establish a business foundation in the growing ...